Endoscopy 2020; 52(S 01): S318-S319
DOI: 10.1055/s-0040-1705027
ESGE Days 2020 ePoster presentations
Thursday, April 23, 2020 09:00 – 17:00 Endoscopic ultrasound ePoster area
© Georg Thieme Verlag KG Stuttgart · New York

PANCREATIC CYSTIC LESIONS: DOCTOR, DO I HAVE PANCREATIC CANCER!?

E Rinja
1   Clinical Emergency Hospital Bucharest, Gastroenterology and Interventional Endoscopy, Bucharest, Romania
,
V Sandru
2   Clinica Emergency Hospital Bucharest UMF Carol Davila, Gastroenterology and Interventional Endoscopy, Bucharest, Romania
,
R Plescuta
1   Clinical Emergency Hospital Bucharest, Gastroenterology and Interventional Endoscopy, Bucharest, Romania
,
A Butuc
1   Clinical Emergency Hospital Bucharest, Gastroenterology and Interventional Endoscopy, Bucharest, Romania
,
D Vascu
3   Clinical Emergency Hospital Bucharest, Bucharest, Romania
,
V Ionescu
1   Clinical Emergency Hospital Bucharest, Gastroenterology and Interventional Endoscopy, Bucharest, Romania
,
R Bala
4   Craiova Emergency Hospital, Gastroenterology and Interventional Endoscopy, Craiova, Romania
,
V Simion
1   Clinical Emergency Hospital Bucharest, Gastroenterology and Interventional Endoscopy, Bucharest, Romania
,
A Constantinescu
1   Clinical Emergency Hospital Bucharest, Gastroenterology and Interventional Endoscopy, Bucharest, Romania
,
B Ungureanu
5   UMF Craiova, Gastroenterology and Interventional Endoscopy, Craiova, Romania
,
G Balan
6   Universitatea de medicina si farmaie ‘Grigore T. Popa’, Gastroenterology and Interventional Endoscopy, Iasi, Romania
,
G Constantineascu
7   Carol Davila School of Medicine, Bucharest, Romania
,
O Plotogea
3   Clinical Emergency Hospital Bucharest, Bucharest, Romania
,
M Ilie
8   Carol Davila School of Medicine, Gastroenterology and Interventional Endoscopy, Bucharest, Romania
› Author Affiliations
Further Information

Publication History

Publication Date:
23 April 2020 (online)

Also available at
 

Aims The prevalence of pancreatic cystic lesions (PCLs), both benign and malignant, has significantly increased in the past few years. We carried out a study aiming to evaluate the frequency of Endoscopic Ultrasound (EUS) based diagnosis of PCLs, with or without fine needle aspiration (FNA), in a tertiary emergency care center.

Methods We conducted a retrospective study assessing a total of 1155 EUS performed by a single operator between 2016 and 2019. Only the EUS findings that were relevant for PCLs were selected and divided into four groups, epithelial neoplastic (EN), epithelial non-neoplastic (ENN), non-epithelial non-neoplastic lesions (NENN) and non-epithelial neoplastic (NEN).

Results Among 1155 EUS performed, 103 (8.92%) met the criteria to be identified as PCLs. From this total, 62 were epithelial neoplastic lesions (60.19%), 26 were epithelial non-neoplastic lesions (25.24%) and 15 were non-epithelial non-neoplastic lesion (14.56%). In every group we assessed the percentage of each type of lesion. In the EN group we added 14 serous cystadenomas (13.59%), 11 serous cystadenocarcinomas (10.68%), 2 mucinous cystadenocarcinomas (1.94%), 12 main duct intraductal papillary mucinous neoplasia (MD-IPMN) (11.65%), 23 branch duct intraductal papillary mucinous neoplasia (BD-IPMN) (22.33%). In the ENN group we added 26 retention

cysts (25.24%), while in the NENN group there were 15 pancreatitis-associated pseudocysts (14.57%).FNA was performed in 30 cases (29.12%) with high suspicion for malignancies, with a confirmed positive diagnosis in 10 cases (9.71%) and were later referred to the surgery and oncological department. Further monitorization was recommended in all cases with low malignancy risk.

Conclusions Given their malignant potential and scarce evidence regarding their true prevalence,

PCLs have been in the medical world spotlight for some years. EUS with or without FNA has proven to be the go-to tool in the diagnosis and monitorization of PCLs with emerging evidence of their increasing frequency.